13F-HR filed by NOVO HOLDINGS A/S
NOVO HOLDINGS A/S filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-14, with 40 holding rows worth $1,353,229,881.
- Accession
- 0000950123-23-010600
- Filer
- CIK 1388325
- Filed
- 2023-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2023
A holdings report, 40 entries on the cover page, a total value of $1,353,229,881 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,353,229,881 with VALUE read as dollars as filed, 13F file number 028-16231. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BROOKFIELD CORP CL A LTD VT SH | 11271J107 | Stock | 3,880,230 | $121,334,792 | dollars as filed | |
| ASMLHLDGNVFSPONSOREDADR1ADRREPS1ORDSHS | N07059210 | STOK | 197,760 | $116,413,402 | dollars as filed | |
| Salesforce.com, Inc | 79466L302 | COM | 530,500 | $107,574,790 | dollars as filed | |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 3,377,768 | $92,044,178 | dollars as filed | |
| LANZATECH GLOBAL INC | 51655R101 | COM | 15,814,845 | $73,855,326 | dollars as filed | |
| CABLE ONE INC | 12685J105 | COM | 118,403 | $72,893,623 | dollars as filed | |
| TAIWAN SEMICONDUCTOR MFG | 874039100 | SPONSORED ADS | 710,780 | $61,766,782 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 1,090,772 | $51,244,485 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 1,500,000 | $47,400,000 | dollars as filed | |
| ALIBABA GROUP HLDG LTD | 01609W102 | SPONSORED ADS | 500,827 | $43,441,734 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 845,000 | $43,078,100 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 1,075,000 | $38,571,000 | dollars as filed | |
| Apple Inc | 037833100 | COM | 221,460 | $37,916,167 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 400,000 | $35,392,000 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 6,071,703 | $34,790,858 | dollars as filed | |
| SEAGEN INC | 81181C104 | COM | 159,986 | $33,941,030 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 1,339,304 | $33,817,426 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 1,100,000 | $32,714,000 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 1,329,325 | $27,743,013 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 525,000 | $26,365,500 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 2,095,900 | $25,486,144 | dollars as filed | |
| RENEO PHARMACEUTICALS INC | 75974E103 | COM | 3,330,377 | $25,344,169 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 1,566,521 | $23,356,828 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 118,383 | $20,965,629 | dollars as filed | |
| BROOKFIELD ASSET MANAGMT LTD CL A LMT VTG SHS | 113004105 | Stock | 627,207 | $20,911,081 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 1,001,000 | $20,510,490 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 1,200,000 | $15,276,000 | dollars as filed | |
| SPRUCE BIOSCIENCES INC | 85209E109 | COM | 6,722,336 | $15,192,479 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 60,000 | $11,906,400 | dollars as filed | |
| IO BIOTECH INC | 449778109 | COM | 5,747,067 | $8,103,364 | dollars as filed | |
| RALLYBIO CORP | 75120L100 | COM | 2,187,999 | $7,373,557 | dollars as filed | |
| ABCELLERA BIOLOGICS INC COM | 00288U106 | Stock | 1,126,915 | $5,183,809 | dollars as filed | |
| SILK ROAD MEDICAL INC | 82710M100 | COMMON STOCK | 333,884 | $5,004,921 | dollars as filed | |
| TREACE MED CONCEPTS INC | 89455T109 | COM | 360,000 | $4,719,600 | dollars as filed | |
| LAVA THERAPEUTICS NV | N51517105 | SHS | 2,400,000 | $3,528,000 | dollars as filed | |
| MARQETA INC | 57142B104 | CLASS A COM | 441,558 | $2,640,517 | dollars as filed | |
| CYTEIR THERAPEUTICS INC | 23284P103 | COMMON | 676,379 | $1,920,916 | dollars as filed | |
| GALECTO INC | 36322Q107 | COM | 2,497,791 | $1,798,410 | dollars as filed | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 815,707 | $1,141,990 | dollars as filed | |
| SPERO THERAPEUTICS INC | 84833T103 | COM | 468,902 | $567,371 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-23-010600 | this filing | 2023-11-14 | acceptance time not in the bulk data set |